Onno van de Stolpe

Last updated

Onno van de Stolpe (born 25 October 1959, Geldrop) is a Dutch businessman and is currently CEO of Galapagos NV, a drug discovery and development company. He will retire in April 2022. [1]

Contents

Education

Van de Stolpe obtained an MSc degree from the Agricultural University in Wageningen (the Netherlands). [2]

Career

Van de Stolpe began his career as Manager Business Development at MOGEN in Leiden. Afterwards, he worked for the Netherlands Foreign Investment Agency in California, where he was responsible for recruiting biotech and medical device companies to locate in the Netherlands.

When he returned to The Netherlands, Van de Stolpe founded Galapagos NV in 1999 when he was recruited by the CEO of Crucell to set up a new genomics division for the company. He launched the division in a join venture with Tibotec. [2]

Since its inception, Van de Stolpe has grown Galapagos NV to almost 600 employees and is one of the largest biotechs in Europe by market cap. [2]

Sources

Related Research Articles

<span class="mw-page-title-main">Wageningen University & Research</span> University in the Netherlands

Wageningen University & Research is a public university in Wageningen, Netherlands, specializing in life sciences with a focus on agriculture, technical and engineering subjects. It is a globally important center for life sciences and agricultural research. It is located in a region of the Netherlands known as the Food Valley.

<span class="mw-page-title-main">Janssen Pharmaceuticals</span> Belgian pharmaceutical company

Janssen Pharmaceuticals is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.

<span class="mw-page-title-main">Hans Wijers</span> Dutch politician and businessman (born 1951)

Gerardus Johannes "Hans" Wijers is a Dutch retired politician of the Democrats 66 (D66) party, and businessman. He is the chairman of the supervisory board of ING Group since 2018.

<span class="mw-page-title-main">DPG Media</span>

DPG Media Group is a Belgian media company also active in the Netherlands and Denmark. It is owned by the Van Thillo family and employs some 6,000 people.

Mediahuis is a newspaper & magazine publishing, distribution, printing, TV, radio and online media company founded in 2014 with assets in Belgium, the Netherlands, Ireland, Luxembourg and Germany. Mediahuis publishes daily newspaper titles in Belgium, the Netherlands and Ireland as well as regional titles, and is involved in broadcasting a number of Dutch and French language TV and radio stations.

<span class="mw-page-title-main">Janssen Vaccines</span> Biotechnology subsidiary of Johnson & Johnson

Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch biotech company Crucell based in Leiden and placed it in their pharmaceutical division.

Paul, Baron Stoffels is a Belgian MD, who studied medicine at the University of Hasselt and the University of Antwerp (UA). In addition he studied Infectious Diseases and Tropical Medicine at the Prince Leopold Institute of Tropical Medicine in Antwerp, Belgium. He is Chief Scientific Officier, Worldwide Chairman of Janssen pharmaceuticals and he is a member of the Johnson & Johnson Executive Committee.

<span class="mw-page-title-main">Christian Van Thillo</span> Belgian businessman (born 1962)

Christian Van Thillo is a Belgian businessman.

Rudi Mariën is a Belgian scientist and businessman. He is chairman of the Belgian biotech company Innogenetics.

<span class="mw-page-title-main">Netherlands–Russia relations</span> Bilateral relations

Netherlands–Russia relations is the relationships between the two countries, the Kingdom of the Netherlands and The Russian Federation. Russia has an embassy in The Hague, and the Netherlands has an embassy in Moscow, a consulate in Saint Petersburg, and an honorary consulate in Yuzhno-Sakhalinsk.

Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index (AScX). The head office of Fagron is located in Rotterdam.

<span class="mw-page-title-main">Agneta Matthes</span> Dutch entrepreneur

Agneta Wilhelmina Johanna van Marken-Matthes was a Dutch entrepreneur. She and her husband Jacques van Marken were involved in the manufacture of yeast throughout their lives, and were engaged in the co-operative movement, taking care of their workers. Matthes and Van Marken created living quarters for workers in her hometown, Delft in South Holland, named Agnetapark after her. These are considered a model for the co-operative development and construction of garden cities for workers. Matthes founded and ran a Delft perfume factory, Maison Neuve, to take advantage of a by-product from the yeast factory.

Arcadis NV is a global design, engineering and management consulting company based in the Zuidas, Amsterdam, Netherlands. It currently operates in excess of 350 offices across 40 countries. The company is a member of the Next 150 index.

Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The outgoing CEO is the Dutchman Onno van de Stolpe and his replacement is Paul Stoffels, effective April 1, 2022.

<span class="mw-page-title-main">Filgotinib</span>

Filgotinib, sold under the brand name Jyseleca, is a medication used for the treatment of rheumatoid arthritis (RA). It was developed by the Belgian-Dutch biotech company Galapagos NV.

<span class="mw-page-title-main">Feike Sijbesma</span> Dutch businessman

Feike Sijbesma is a Dutch business executive who served as CEO and Chairman of the Managing Board of DSM from 2007 until 2020. And in 2022, he was nominated as honorary chariman. He helped the Dutch government from March till September 2020 as special voluntary corona envoy, especially focused on testing policy and availability. From mid 2020 Sijbesma focuses on several board positions and the African malnutrition issue and climate (adaptation).

Bas Burger is a Dutch business executive known for his work in the international telecom industry. Currently CEO, Global Services, BT, he is a contributor to the World Economic Forum and is on the Committee for Economic Development.

Onno is a Dutch masculine given name of unclear origin. People with the name include:

<span class="mw-page-title-main">VodafoneZiggo</span>

VodafoneZiggo Group Holding B.V. is a Dutch joint venture between Vodafone Plc and Ziggo B.V., announced in February 2016, approved by the European Commission in August 2016 and completed in December 2016.

<span class="mw-page-title-main">ProQR</span> Dutch biotechnology company

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. The company was funded in 2012 by chief executive officer (CEO) Daniel de Boer. It specializes in the development of RNA therapeutics for rare genetic diseases with an ophthalmologic application.

References

  1. "Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO". Reuters. 26 January 2022.
  2. 1 2 3 "Onno van de Stolpe: Founder & CEO of Galapagos". Labiotech.eu. 2017-09-25. Retrieved 2017-12-14.